Lamictal vs Topamax: side-by-side comparison
Lamictal (Lamotrigine) and Topamax (Topiramate) both belong to the Neurological Medications class. They share clinical context but use different active ingredients. The choice between them depends on mechanism nuances, side-effect profile and individual response.
| Property | Lamictal | Topamax |
|---|---|---|
| Active ingredient | Lamotrigine | Topiramate |
| Manufacturer | GlaxoSmithKline | Janssen |
| Class | Neurological Medications | Neurological Medications |
| Strengths | 25mg, 50mg, 100mg, 200mg | 25mg, 50mg, 100mg, 200mg |
| Forms | tablet, chewable tablet, orally disintegrating tablet, extended-release tablet | tablet, sprinkle capsule, extended-release capsule |
What's the same
Lamictal and Topamax both belong to the Neurological Medications class and are used for partially overlapping indications. The active ingredients — Lamotrigine vs Topiramate — share the same therapeutic approach, so many safety and management points carry across both.
Key differences
Meaningful differences are in active ingredient (Lamotrigine vs Topiramate), strengths (25mg, 50mg, 100mg, 200mg vs 25mg, 50mg, 100mg, 200mg), forms (tablet, chewable tablet, orally disintegrating tablet, extended-release tablet vs tablet, sprinkle capsule, extended-release capsule), and the mechanism, half-life and side-effect nuances that distinguish members of the class.
Mechanism and action
Lamictal: Lamotrigine selectively blocks voltage-gated sodium channels, stabilising neuronal membranes and reducing the release of excitatory neurotransmitters, particularly glutamate. Topamax: Topiramate has multiple mechanisms of action: blockade of voltage-gated sodium channels, enhancement of gamma-aminobutyric acid (GABA) activity at non-benzodiazepine GABA-A receptor sites, antagonism of glutamate at AMPA…
When Lamictal is preferred
Lamictal is approved in adults and children aged 2 years and older as adjunctive or monotherapy for partial-onset seizures, primary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome.
When Topamax is preferred
Topamax is approved in adults and children aged 2 years and older for the treatment of partial-onset seizures, primary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome (as adjunctive or monotherapy depending on the country and indication).
Frequently asked questions
Is Lamictal or Topamax better? ▾
There is no single answer. Lamictal and Topamax both belong to the Neurological Medications class but differ in mechanism nuances, half-life and side-effect profile. Preference depends on the patient, the prescriber and prior response to other therapies.
Can I switch from Lamictal to Topamax? ▾
Switching within the Neurological Medications class is done under supervision, typically using equivalent doses and a follow-up period to confirm response and tolerance. It is not a self-directed decision.
Do Lamictal and Topamax have the same side effects? ▾
They share many of the Neurological Medications class side effects, with differences from mechanism and dose. Each medication's prescribing information lists specifics.
More Lamictal comparisons
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.